Nature published two biomedical papers that could, in a decade, look like inflection points; a brown dwarf turns out to have a planet-mass companion; and it turns out human evolution didn't stop when agriculture started.
A single-dose gene therapy trial published in Nature has produced near-complete seizure cessation in a cohort of children with KCNQ2-related epilepsy, a severe form with no prior effective treatment. One participant, previously unable to stand, began walking within four months of treatment. The mechanism targets potassium channel dysfunction at the source.
Researchers have repurposed a CRISPR-associated nuclease to identify and destroy cancer cells by targeting a DNA instability signature common across tumour types but absent in healthy tissue. In mouse models, a single injection eliminated 80% of tumour cells within two weeks without apparent off-target effects. Nature paper published 26 July.
Astronomers have detected a planetary-mass object orbiting a brown dwarf companion to a nearby star — the clearest candidate for an exosatellite observed to date. The object, roughly Neptune-mass, sits in an orbital configuration that models struggle to explain via standard formation pathways, suggesting either capture or an unusually compact protoplanetary disc.
A Harvard-led analysis of 500,000 biobank participants finds statistically robust signals of ongoing natural selection in 87 gene variants — including some linked to late-onset disease, educational attainment, and reproductive timing. The strength of selection signals is modest but unmistakable, refuting the common claim that modern medicine has neutralised evolutionary pressure.
SpaceX's eleventh Starship test flight successfully deployed 20 next-generation Starlink satellites — the vehicle's first operational payload delivery. Both the Super Heavy booster and the Ship upper stage completed controlled landings, with the booster caught again by the mechanical arms at the Starbase launch site.
The European Physical Society has awarded its 2026 Condensed Matter Physics prize to the team that characterised altermagnetism — a newly classified magnetic phase that shares properties of both ferromagnetism and antiferromagnetism but obeys neither's rules. The prize is the field's formal acknowledgement that the textbook now needs a third column.